
Conference Coverage
Latest Content

Shorts






Podcasts
Videos
All News

Combining Rituxan with Mavenclad or Zelboraf upfront can extend remissions safely and should become standard first-line therapy for hairy cell leukemia.

The FDA has granted fast track designation to MT-125 for the treatment of patients with glioblastoma.

The FDA approved Blenrep with Velcade and dexamethasone for relapsed or refractory multiple myeloma.

What you need to know about stomach cancer, also known as gastric cancer.

Even after all these years with small lymphocytic lymphoma, I’ve accepted that the scares will never completely go away — but neither will my resilience.

CURE sat down with Dr. Kerry A. Rogers for an interview at the Hairy Cell Leukemia Foundation 2025 Conference, hosted in Bologna, Italy.

Here is a basic guide to what you need to know about stage 2 papillary thyroid cancer.

What are we supposed to do to be a “true” friend to someone who is facing cancer?

The Food and Drug Administration granted fast track designation to HDP-101 for the treatment of multiple myeloma.

The MELODY study found music therapy to be effective at relieving the anxiety of cancer survivors.

Denial is a very powerful thing, but it is one that can have serious negative consequences.

After being diagnosed with stage 3 triple-negative breast cancer at 29, Meagan Pettit urges young adults to seek community and define life beyond diagnosis.

Fran Curtis is a survivor of breast, appendix and skin cancer, but said bladder cancer was the toughest.

The story of prevention doesn't end with a surgery date or a clean scan — it unfolds over decades, shaped by habits, choices and vigilance.

In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.


























